Cytosorbents Corp reports results for the quarter ended in March - Earnings Summary
09/05/2024 23:05
* Cytosorbents Corp CTSO.OQ reported a quarterly adjusted
loss
of 12 cents per share for the quarter ended in March, higher
than the same quarter last year, when the company reported EPS
of -17 cents. The mean expectation of three analysts for the
quarter was for a loss of 12 cents per share. Wall Street
expected results to range from -15 cents to -10 cents per share.
* Revenue rose 3.6% to $9.79 million from a year ago;
analysts
expected $9.78 million.
* Cytosorbents Corp's reported EPS for the quarter was a
loss
of 12 cents.
* The company reported a quarterly loss of $6.36 million.
* Cytosorbents Corp shares had fallen by 8.2% this
quarter and
lost 21.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 7.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Cytosorbents Corp
is $4.00
This summary was machine generated from LSEG data May 9 at 10:04
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.12 -0.12 Met
Dec. 31 2023 -0.14 -0.13 Beat
Sep. 30 2023 -0.14 -0.21 Missed
Jun. 30 2023 -0.11 -0.14 Missed